… of dapagliflozin on EAT volume and P-wave indices. Methods: In the present ad hoc analysis…
disease were classified into dapagliflozin group (n=18) and conventional treatment group (n…

… this analysis, as it does not capture the potential effect of this new therapy on health care
service … are associated with benefits not captured in this analysis, such as weight loss, improved …

… Dapagliflozin reduced the risk of kidney failure in patients … specified analysis, we assessed
the effect of dapagliflozin on … coefficient of treatment to estimate the effect of dapagliflozin on …

… Efficacy outcomes were analyzed excluding data after rescue, with the exception of weight-…
according to insulin use (ad hoc analysis). Post hoc analyses were conducted in participants …

… analyses included subgroups according to stratification factors and eGFR (<90 or ≥90
mL/min/1.73 m 2 ) at screening. As ad hoc analyses, … UACR ≥30 mg/g) were analyzed (n=18 in …

… With acknowledgment that race is a social construct, Black and White patients appeared
to experience similar kidney and cardiovascular benefits of dapagliflozin in this study. …

… based on the available individual patient-level data in a one-stage meta-analysis. In this
prespecified exploratory analysis, we examined the effect of dapagliflozin versus placebo on …

… Background treatment subgroups In this post hoc analysis, we compared the effect of
dapagliflozin with placebo in subgroups of patients treated with other background pharmacological …

… -hoc analyses of several type 2 diabetes subgroups examined dapagliflozin treatment effect
… Finally, we did a post-hoc analysis of the effect of dapagliflozin on the primary outcome rates …

… Finally, we aim to investigate if dapagliflozin treatment increases insulin and glucagon
secretion in patients with obesity. Chronic hyperglycemia leads to a defect in insulin production …